Debunking Psoriasis Myths: Do Systemic Steroids Used in Psoriasis Patients Cause Pustular Psoriasis?
The advent of biologic therapy for psoriasis has changed the landscape of treatments offered to…
mdedge.com
Modest Efficacy for Methotrexate in Psoriasis
Doubt remains regarding the appropriateness, efficacy and safety of methotrexate in the treatment of moderate to severe cutaneous psoriasis. Moreover, high dose,…
rheumnow.com
Subcutaneous high-dose methotrexate controls psoriasis
A little-studied route of methotrexate delivery produces rapid and sustained responses in moderate to severe psoriasis patients.
mdedge.com
Inhibition of phosphodiesterase 4 (PDE4) reduces dermal fibrosis by interfering with the release of interleukin-6 from M2 macrophages
ard.bmj.com
Valeants Brodalumab FDA Approved for Psoriasis
The drug was originally developed by Amgen…
rheumnow.com
Guselkumab Shows Superiority in Plaque Psoriasis Phase 3 Studies
Janssen announced new findings from VOYAGE 2 and NAVIGATE, two pivotal Phase 3 studies evaluating guselkumab for the treatment of moderate to…
empr.com